{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:36:11Z","timestamp":1782218171047,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biopha.2017.02.019","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T01:17:41Z","timestamp":1487294261000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma"],"prefix":"10.1016","volume":"89","author":[{"given":"Esam M.","family":"Aboubakr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Taye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Gamal-Eldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"El-Moselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2017.02.019_bib0005","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4254\/wjh.v7.i12.1632","article-title":"Guide for diagnosis and treatment of hepatocellular carcinoma","volume":"7","author":"Attwa","year":"2015","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2017.02.019_bib0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cllc.2013.06.007","article-title":"Structural basis for hyperpermeability of tumor vessels in advanced lung adenocarcinoma complicated by pleural effusion","volume":"14","author":"Damianovich","year":"2013","journal-title":"Clin. Lung Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2017.02.019_bib0015","doi-asserted-by":"crossref","first-page":"e84236","DOI":"10.1371\/journal.pone.0084236","article-title":"Xenograft tumors vascularized with murine blood vessels may overestimate the effect of anti-tumor drugs: a pilot study","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2017.02.019_bib0020","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00270-010-9846-6","article-title":"Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study","volume":"33","author":"Deschamps","year":"2010","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.biopha.2017.02.019_bib0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2741\/3796","article-title":"Vasculogenensis, angiogenesis and special features of tumor blood vessels","volume":"16","author":"Hiratsuka","year":"2011","journal-title":"Front. Biosci."},{"issue":"10","key":"10.1016\/j.biopha.2017.02.019_bib0030","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/ijc.28269","article-title":"Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle delivery","volume":"133","author":"Fu","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2017.02.019_bib0035","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/1535-7163.MCT-10-0706","article-title":"Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy","volume":"9","author":"Bohndiek","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.biopha.2017.02.019_bib0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3109\/1061186X.2014.1002789","article-title":"Trapping effect on a small molecular drug with vascular-disrupting agent CA4-P in rodent H22 hepatic tumor model: in vivo magnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy","volume":"23","author":"Gao","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biopha.2017.02.019_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2015.05.034","article-title":"Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model","volume":"100","author":"Gagne-Boulet","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2017.02.019_bib0050","article-title":"Exploring beta-tubulin inhibitors from plant origin using computational approach","author":"Verma","year":"2016","journal-title":"Phytochem. Anal."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2017.02.019_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1026045100219","article-title":"Antimicrotubular drugs binding to vinca domain of tubulin","volume":"253","author":"Gupta","year":"2003","journal-title":"Mol. Cell Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2017.02.019_bib0060","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.transproceed.2005.03.024","article-title":"Successful treatment of liver transplant-associated Kaposi's sarcoma with long-term vincristine","volume":"37","author":"Akay","year":"2005","journal-title":"Transplant.Proc."},{"issue":"8","key":"10.1016\/j.biopha.2017.02.019_bib0065","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/neuonc\/nov057","article-title":"A pilot study using carboplatin, vincristine, and temozolomide in children with progressive\/symptomatic low-grade glioma: a Children\u2019s Oncology Group studydagger","volume":"17","author":"Chintagumpala","year":"2015","journal-title":"Neuro-oncology"},{"issue":"6","key":"10.1016\/j.biopha.2017.02.019_bib0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF02759902","article-title":"Vincristine induced cranial polyneuropathy","volume":"73","author":"Bay","year":"2006","journal-title":"Indian J. Pediatr."},{"issue":"6","key":"10.1016\/j.biopha.2017.02.019_bib0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPH.0b013e3181a7153e","article-title":"Vincristine induced unilateral ptosis","volume":"31","author":"Dejan","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12098-009-0254-3","article-title":"Vincristine induced neurotoxicity in cancer patients","volume":"77","author":"Gomber","year":"2010","journal-title":"Indian J. Pediatr."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.019_bib0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10637-015-0215-9","article-title":"Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation","volume":"33","author":"Mahal","year":"2015","journal-title":"Investig. New Drugs"},{"issue":"7","key":"10.1016\/j.biopha.2017.02.019_bib0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3727\/096504011X13079697132790","article-title":"Combretastatin A4 phosphate induces programmed cell death in vascular endothelial cells","volume":"19","author":"Ding","year":"2011","journal-title":"Oncol. Res."},{"issue":"12","key":"10.1016\/j.biopha.2017.02.019_bib0095","first-page":"3408","article-title":"A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer","volume":"62","author":"Dowlati","year":"2002","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.019_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1549-8719.2012.00160.x","article-title":"The vascular-disrupting agent combretastatin impairs splitting and sprouting forms of physiological angiogenesis","volume":"19","author":"Hussain","year":"2012","journal-title":"Microcirculation"},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3835(01)00681-4","article-title":"In vitro bioassays for anticancer drug screening: effects of cell concentration and other assay parameters on growth inhibitory activity","volume":"173","author":"Lieberman","year":"2001","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jat.1564","article-title":"Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line","volume":"31","author":"Lordan","year":"2011","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2017.02.019_bib0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0003-2697(03)00436-6","article-title":"A tubulin-based fluorescent polarization assay for paclitaxel","volume":"321","author":"Morais","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.02.019_bib0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0091-679X(08)60248-4","article-title":"A quantitative solid-phase binding assay for tubulin","volume":"37","author":"Thrower","year":"1993","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.biopha.2017.02.019_bib0130","first-page":"49","article-title":"Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling","volume":"30","author":"Abdel aziz","year":"2011","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"2","key":"10.1016\/j.biopha.2017.02.019_bib0135","first-page":"316","article-title":"Melatonin modulates the oxidant-antioxidant imbalance during N-nitrosodiethylamine induced hepatocarcinogenesis in rats, Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences","volume":"8","author":"Dakshayani","year":"2005","journal-title":"Societe canadienne des sciences pharmaceutiques"},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.18388\/abp.2009_2528","article-title":"Combination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumors","volume":"56","author":"Mitrus","year":"2009","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.biopha.2017.02.019_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-3155-10-5","article-title":"Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration","volume":"10","author":"Abdelhalim","year":"2012","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2017.02.019_bib0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0003-2697(66)90167-9","article-title":"Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems","volume":"16","author":"Placer","year":"1966","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.02.019_bib0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxidative damage to proteins: spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2017.02.019_bib0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0076-6879(94)33040-9","article-title":"Carbonyl assays for determination of oxidatively modified proteins","volume":"233","author":"Levine","year":"1994","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0003-2697(74)90006-2","article-title":"Enzymic method for the quantitative determination of reduced glutathione","volume":"59","author":"Koivusalo","year":"1974","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am. J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.biopha.2017.02.019_bib0175","doi-asserted-by":"crossref","first-page":"e0142876","DOI":"10.1371\/journal.pone.0142876","article-title":"Early assessment of colorectal cancer patients with liver metastases treated with antiangiogenic drugs: the role of intravoxel incoherent motion in diffusion-weighted imaging","volume":"10","author":"Granata","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2017.02.019_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152012800228841","article-title":"Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids","volume":"12","author":"Coderch","year":"2012","journal-title":"Anti-cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bmcl.2014.10.090","article-title":"Antimitotic activity of structurally simplified biaryl analogs of the anticancer agents colchicine and combretastatin A4","volume":"25","author":"McNulty","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2017.02.019_bib0190","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2174\/0929867322666150114163732","article-title":"Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments","volume":"22","author":"Ji","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.019_bib0195","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.etap.2015.08.028","article-title":"Diaryl sulfide analogs of combretastatin A-4: Toxicogenetic, immunomodulatory and apoptotic evaluations and prospects for use as a new chemotherapeutic drug","volume":"40","author":"Carvalho","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.019_bib0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/157340607781024366","article-title":"Combretastatin-chalcone hybrids: synthesis and cytotoxicity","volume":"3","author":"Nam","year":"2007","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2017.02.019_bib0205","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.2147\/DDDT.S113838","article-title":"Andrographolide promotes vincristine-induced SK-NEP-1 tumor cell death via PI3K-AKT-p53 signaling pathway","volume":"10","author":"Zhang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.019_bib0210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/fcp.12043","article-title":"Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines","volume":"28","author":"Badinloo","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2017.02.019_bib0215","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1039\/C4CC09390A","article-title":"Interaction of Abeta peptide with tubulin causes an inhibition of tubulin polymerization and the apoptotic death of cancer cells","volume":"51","author":"Saha","year":"2015","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.biopha.2017.02.019_bib0220","article-title":"Mechanisms of tubulin binding ligands to target cancer cells: updates on their therapeutic potential and clinical trials","author":"Kumar","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2017.02.019_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/112_2013_16","article-title":"Pharmacological inhibition of actin assembly to target tumor cell motility","volume":"166","author":"Nurnberg","year":"2014","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2017.02.019_bib0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/156800912798888956","article-title":"The critical role of vascular endothelial growth factor in tumor angiogenesis","volume":"12","author":"Amini","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2017.02.019_bib0235","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.1038\/srep08587","article-title":"Responses of solid tumor cells in DMEM to reactive oxygen species generated by non-thermal plasma and chemically induced ROS systems","volume":"5","author":"Kaushik","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2017.02.019_bib0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/ijmm.2015.2073","article-title":"Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death","volume":"35","author":"Liu","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.02.019_bib0245","first-page":"143","article-title":"Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI","volume":"5","author":"Zhou","year":"2015","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.biopha.2017.02.019_bib0250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1515\/ap-2015-0105","article-title":"Malondialdehyde; Lipid peroxidation plasma biomarker correlated with hepatic fibrosis in human Schistosoma mansoni infection","volume":"60","author":"Aziz","year":"2015","journal-title":"Acta Parasitol."},{"issue":"5","key":"10.1016\/j.biopha.2017.02.019_bib0255","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3892\/or.2014.3064","article-title":"Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1alpha expression","volume":"31","author":"Qi","year":"2014","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2017.02.019_bib0260","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s13277-014-2743-x","article-title":"Redox cycling of Cu(II) by 6-mercaptopurine leads to ROS generation and DNA breakage: possible mechanism of anticancer activity","volume":"36","author":"Rehman","year":"2015","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.biopha.2017.02.019_bib0265","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.28637","article-title":"Hepatocellular carcinoma repression by TNFalpha-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization","volume":"64","author":"Li","year":"2016","journal-title":"Hepatology"},{"issue":"45","key":"10.1016\/j.biopha.2017.02.019_bib0270","doi-asserted-by":"crossref","first-page":"32343","DOI":"10.1074\/jbc.M113.455188","volume":"288","author":"Gupta","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.biopha.2017.02.019_bib0275","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2003-04-1039","article-title":"Selective targeted delivery of TNFalpha to tumor blood vessels","volume":"102","author":"Borsi","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2017.02.019_bib0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10585-015-9704-7","article-title":"Anti-metastatic activity of the tumor vascular targeting agent NGR-TNF","volume":"32","author":"Di Matteo","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"issue":"10","key":"10.1016\/j.biopha.2017.02.019_bib0285","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2217\/fon.10.122","article-title":"ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy","volume":"6","author":"Baguley","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2017.02.019_bib0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2015.12.009","article-title":"TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors","volume":"423","author":"Hantel","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2017.02.019_bib0295","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2016.04.045","article-title":"Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms","volume":"784","author":"Chang","year":"2016","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217301178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217301178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:03:55Z","timestamp":1760094235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217301178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":59,"alternative-id":["S0753332217301178"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.019","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}